HPV vaccination: Are we initiating too late?

Vaccine

Volumn 32, Issue 17, 2014, Pages 1939-1945

  Hofstetter, Annika M ^a,b   Stockwell, Melissa S ^a,b,c   Al Husayni, Noor ^a   Ompad, Danielle ^c,d   Natarajan, Karthik ^a,b   Rosenthal, Susan L ^a,b   Soren, Karen ^a,b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Department of Population and Family Health Mailman School of Public Health Columbia University ^*  (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

Chlamydia; Human papillomavirus; Initiation; Papanicolaou; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENCE; ADOLESCENT; ADULT; AMBULATORY CARE; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; COHORT ANALYSIS; FEMALE; HIGH RISK POPULATION; HUMAN; INFECTION RISK; LANGUAGE; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MINORITY GROUP; MORBIDITY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCREENING TEST; SEXUAL INTERCOURSE; VACCINATION; YOUNG ADULT;

CHLAMYDIA; HUMAN PAPILLOMAVIRUS; INITIATION; PAPANICOLAOU; VACCINATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MINORITY GROUPS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POVERTY; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 84896313522     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.084     Document Type: Article

References (47)

1. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human Papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
2. Winer R.L., Lee S.K., Hughes J.P., Adam D.E., Kiviat N.B., Koutsky L.A. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157(3):218-226.
3. Giuliano A.R., Lazcano-Ponce E., Villa L., Nolan T., Marchant C., Radley D., Golm G., McCarroll K., Yu J., Esser M.T., et al. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. J Infect Dis 2007, 196(8):1153-1162.
4. Block S.L., Nolan T., Sattler C., Barr E., Giacoletti K.E., Marchant C.D., Castellsague X., Rusche S.A., Lukac S., Bryan J.T., et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 2006, 118(5):2135-2145.
5. Dobson S.R., McNeil S., Dionne M., Dawar M., Ogilvie G., Krajden M., Sauvageau C., Scheifele D.W., Kollmann T.R., Halperin S.A., et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. JAMA 2013, 309(17):1793-1802.
6. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007, 161(3):252-259.
7. Bair R.M., Mays R.M., Sturm L.A., Zimet G.D. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 2008, 21(6):329-334.
8. Dempsey A.F., Abraham L.M., Dalton V., Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009, 19(8):531-538.
9. Centers for Disease Control and Prevention National and state vaccination coverage among adolescents aged 13-17 years-United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61(34):671-677.
10. Centers for Disease Control and Prevention Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States. MMWR Morb Mortal Wkly Rep 2013, 62(29):591-595.
11. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., Babbel C., Gottlieb S.L., Liddon N., Stokley S., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126(3):425-433.
12. Vadaparampil S.T., Kahn J.A., Salmon D., Lee J.H., Quinn G.P., Roetzheim R., Bruder K., Malo T.L., Proveaux T., Zhao X., et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011, 29(47):8634-8641.
13. Kahn J.A., Cooper H.P., Vadaparampil S.T., Pence B.C., Weinberg A.D., LoCoco S.J., Rosenthal S.L. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009, 18(8):2325-2332.
14. Wong C.A., Taylor J.A., Wright J.A., Opel D.J., Katzenellenbogen R.A. Missed opportunities for adolescent vaccination, 2006-2011. J Adolesc Health 2013, 53(4):492-497.
15. Neubrand T.P., Breitkopf C.R., Rupp R., Breitkopf D., Rosenthal S.L. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila) 2009, 48(9):966-969.
16. Widdice LE, Brown DR, Bernstein DI, Ding L, Patel D, Shew M, Fortenberry JD, Kahn JA: Prevalence of human papillomavirus infection in young women receiving the first quadrivalent vaccine dose. Arch Pediatr Adolesc Med, 166(8):774-776.
17. Jaccard J., Dittus P.J., Gordon V.V. Parent-adolescent congruency in reports of adolescent sexual behavior and in communications about sexual behavior. Child Dev 1998, 69(1):247-261.
18. Mollborn S., Everett B. Correlates and consequences of parent-teen incongruence in reports of teens' sexual experience. J Sex Res 2010, 47(4):314-329.
19. Hughes C.C., Jones A.L., Feemster K.A., Fiks A.G. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 2011, 11:74.
20. New York City Department of City Planning Manhattan Community District 12 2013, New York City Department of City Planning, Inwood, Washington Heights, [cited March 8, 2013] Available from: 〈http://www.nyc.gov/html/dcp/html/neigh_info/mn12_info.shtml.
21. Metroka A.E., Hansen M.A., Papadouka V., Zucker J.R. Using an immunization information system to improve accountability for vaccines distributed through the Vaccines for Children program in New York City, 2005-2008. J Public Health Manage Pract 2009, 15(5):E13-E21.
22. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., Raab S., Sherman M., Wilbur D., Wright T., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287(16):2114-2119.
23. Markowitz L.E., Hariri S., Lin C., Dunne E.F., Steinau M., McQuillan G., Unger E.R. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 2013, 208(3):385-393.
24. Hofstetter A.M., Natarajan K., Martinez R.A., Rabinowitz D., Vawdrey D.K., Stockwell M.S. Influenza vaccination coverage and timeliness among children requiring two doses, 2004-2009. Prev Med 2013, 56(3-4):165-170.
25. Stockwell M.S., Martinez R.A., Hofstetter A., Natarajan K., Vawdrey D.K. Timeliness of 2009 H1N1 vaccine coverage in a low-income pediatric and adolescent population. Vaccine 2013, 31(16):2103-2107.
26. Kelminson K., Saville A., Seewald L., Stokley S., Dickinson L.M., Daley M.F., Suh C., Kempe A. Parental views of school-located delivery of adolescent vaccines. J Adolesc Health 2012, 51(2):190-196.
27. Prislin R., Suarez L., Simpson D.M., Dyer J.A. When acculturation hurts: the case of immunization. Soc Sci Med 1998, 47(12):1947-1950.
28. Brewer N.T., Gottlieb S.L., Reiter P.L., McRee A.L., Liddon N., Markowitz L., Smith J.S. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2010, 38(3):197-204.
29. Freed G.L., Clark S.J., Butchart A.T., Singer D.C., Davis M.M. Parental vaccine safety concerns in 2009. Pediatrics 2010, 125(4):654-659.
30. Darden P.M., Thompson D.M., Roberts J.R., Hale J.J., Pope C., Naifeh M., Jacobson R.M. Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics 2013, 131(4):645-651.
31. Dorell C., Yankey D., Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, National Immunization Survey-Teen, 2009. Clin Pediatr (Phila) 2011, 50(12):1116-1124.
32. Marlow L.A., Forster A.S., Wardle J., Waller J. Mothers' and adolescents' beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009, 44(5):446-451.
33. Bednarczyk R.A., Davis R., Ault K., Orenstein W., Omer S.B. Sexual activity-related outcomes after human papillomavirus vaccination of 11- to 12-year-olds. Pediatrics 2012, 130(5):798-805.
34. Cummings T., Zimet G.D., Brown D., Tu W., Yang Z., Fortenberry J.D., Shew M.L. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012, 30(37):5496-5500.
35. Forster A., Wardle J., Stephenson J., Waller J. Passport to promiscuity or lifesaver: press coverage of HPV vaccination and risky sexual behavior. J Health Commun 2010, 15(2):205-217.
36. Mullins T.L., Zimet G.D., Rosenthal S.L., Morrow C., Ding L., Shew M., Fortenberry J.D., Bernstein D.I., Kahn J.A. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012, 166(1):82-88.
37. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
38. Lau M., Lin H., Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012, 30(20):3112-3118.
39. Ylitalo K.R., Lee H., Mehta N.K. Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health 2012, 103(1):164-169.
40. Guerry S.L., De Rosa C.J., Markowitz L.E., Walker S., Liddon N., Kerndt P.R., Gottlieb S.L. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011, 29(12):2235-2240.
41. Mayne S., Karavite D., Grundmeier R.W., Localio R., Feemster K., Debartolo E., Hughes C.C., Fiks A.G. The implementation and acceptability of an HPV vaccination decision support system directed at both clinicians and families. AMIA Annu Symp Proc 2012, 616-624.
42. Haydon A.A., Herring A.H., Prinstein M.J., Halpern C.T. Beyond age at first sex: patterns of emerging sexual behavior in adolescence and young adulthood. J Adolesc Health 2012, 50(5):456-463.
43. Martinez G., Copen C.E., Abma J.C. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat 2012, 23(31):1-35.
44. Centers for Disease Control and Prevention Sexually transmitted disease surveillance, 2011 2012, Centers for Disease Control and Prevention, [cited March 24, 2013]; Available from 〈http://www.cdc.gov/std/stats11/Surv2011.pdf〉.
45. Tu W., Batteiger B.E., Wiehe S., Ofner S., Van Der Pol B., Katz B.P., Orr D.P., Fortenberry J.D. Time from first intercourse to first sexually transmitted infection diagnosis among adolescent women. Arch Pediatr Adolesc Med 2009, 163(12):1106-1110.
46. Goldberg S.K., Haydon A.A., Herring A.H., Halpern C.T. Longitudinal consistency in self-reported age of first vaginal intercourse among young adults. J Sex Res 2014, 51(1):97-106.
47. AC OG Practice Bulletin no.109 Cervical cytology screening. Obstet Gynecol 2009, 114(6):1409-1420.